Instil Bio Inc (TIL)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Instil Bio: Overcoming Financial Challenges and Paving the Way for Cancer Therapies
Instil Bio Inc Shocks Investors with Operating Shortfall in Q3 2023
Instil Bio Inc Faces Financial Challenges and Warns Investors to Proceed with Caution
Instil Bio Inc reported Revenue of $17.224 millions, in the fourth quarter of 2022 earnings season
reported operating deficit of $-56.649 millions, in the Sep 30 2022 report